FDA Drug recall D-0178-2022
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, Sa…
- FDA Drug
- Class II
- terminated
- Published 2021-11-17
On 2021-11-17 the FDA classified a Class II recall of TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, Sa… by Vita Pharmacy, citing lack of assurance of sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0178-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-10-12 |
| Published | 2021-11-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Vita Pharmacy |
| Distribution | PR, WA |
Product
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
Reason
Lack of assurance of sterility
Identifiers
| code_info | Lot: T1006042021:60 BUD: 12/01/2021; T1008302021:63 BUD: 02/26/2022; T1005122021:36 BUD: 11/08/2021; T1007142021:23 BUD…Lot: T1006042021:60 BUD: 12/01/2021; T1008302021:63 BUD: 02/26/2022; T1005122021:36 BUD: 11/08/2021; T1007142021:23 BUD: 01/10/2022; T1008192021:94 BUD: 02/15/2022; 04202021:80 BUD: 10/17/2021; T1007012021:31 BUD: 12/28/2021; T1009092021:97 BUD: 03/08/2022; T1004092021:79 BUD: 10/06/2021; T1005242021:08 BUD: 11/20/2021; T1008092021:82 BUD: 02/05/2022; T1005042021:92 BUD: 10/31/2021; T1007262021:03 BUD: 01/22/2022; T1006172021:47 BUD: 12/14/2021 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0178-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.